Abstract
The present work addresses the analyses of some novel kinetic parameters ( k t, K v, t 50, K ir, t c, m c, IC 50, IC 99 and K i) of human erythrocyte membrane-bound acetylcholinesterase (AChE, EC 3.1.1.7) inhibition by cis-diamminediaquaplatinum II (PDC). PDC is under a clinical trial for use as an antineoplastic drug. The authors recently reported that PDC and cisplatin have the ability to inhibit AChE activity in vitro. Therefore this study was designed to determine the estimation of time constant ( k t), velocity constant ( K v), 50% inhibition time ( t 50), inhibition rate constant ( K ir), transition concentration ( t c), meeting concentration ( m c), 50% inhibition (IC 50), 99% inhibition (IC 99) and inhibition constant ( K i) by novel methods. The details are described in the text.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
